Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

Entrada Therapeutics (TRDA) Other Gross PP&E Adjustments (2022 - 2025)

Entrada Therapeutics has reported Other Gross PP&E Adjustments over the past 4 years, most recently at -$46.4 million for Q4 2025.

  • Quarterly results put Other Gross PP&E Adjustments at -$46.4 million for Q4 2025, up 12.81% from a year ago — trailing twelve months through Dec 2025 was -$46.4 million (up 12.81% YoY), and the annual figure for FY2025 was -$46.4 million, up 12.81%.
  • Other Gross PP&E Adjustments for Q4 2025 was -$46.4 million at Entrada Therapeutics, down from -$43.5 million in the prior quarter.
  • Over the last five years, Other Gross PP&E Adjustments for TRDA hit a ceiling of -$1.0 million in Q1 2023 and a floor of -$72.9 million in Q2 2023.
  • Median Other Gross PP&E Adjustments over the past 4 years was -$46.9 million (2025), compared with a mean of -$43.2 million.
  • Biggest five-year swings in Other Gross PP&E Adjustments: skyrocketed 95.48% in 2023 and later tumbled 5942.55% in 2024.
  • Entrada Therapeutics' Other Gross PP&E Adjustments stood at -$15.5 million in 2022, then tumbled by 327.26% to -$66.1 million in 2023, then increased by 19.52% to -$53.2 million in 2024, then grew by 12.81% to -$46.4 million in 2025.
  • The last three reported values for Other Gross PP&E Adjustments were -$46.4 million (Q4 2025), -$43.5 million (Q3 2025), and -$44.5 million (Q2 2025) per Business Quant data.